Kezar Life Sciences
123 hedge funds and large institutions have $401M invested in Kezar Life Sciences in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 55 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $480M → $401M (-$79.2M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Holders
123
Holding in Top 10
3
Calls
$1.49M
Puts
$27K
Top Buyers
| 1 | +$19.8M | |
| 2 | +$10.1M | |
| 3 | +$9.63M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.04M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$4.06M |
Top Sellers
| 1 | -$20.3M | |
| 2 | -$13.8M | |
| 3 | -$8.18M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$4.55M |